UBS Group’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.25M Buy
527,611
+231,594
+78% +$2.07M ﹤0.01% 4037
2025
Q4
$2.5M Buy
296,017
+143,764
+94% +$1.03M ﹤0.01% 4754
2025
Q3
$795K Sell
152,253
-20,837
-12% -$79.5K ﹤0.01% 5744
2025
Q2
$599K Sell
173,090
-102,468
-37% -$305K ﹤0.01% 5861
2025
Q1
$722K Sell
275,558
-67,688
-20% -$265K ﹤0.01% 5562
2024
Q4
$1.41M Buy
343,246
+151,522
+79% +$825K ﹤0.01% 5034
2024
Q3
$1.36M Buy
191,724
+2,404
+1% +$18K ﹤0.01% 4362
2024
Q2
$1.23M Sell
189,320
-98,606
-34% -$674K ﹤0.01% 4218
2024
Q1
$2.39M Buy
287,926
+101,627
+55% +$991K ﹤0.01% 3765
2023
Q4
$2.05M Buy
186,299
+125,340
+206% +$1.06M ﹤0.01% 3797
2023
Q3
$513K Sell
60,959
-133,738
-69% -$1.44M ﹤0.01% 4634
2023
Q2
$2.45M Buy
194,697
+24,034
+14% +$299K ﹤0.01% 3337
2023
Q1
$2.81M Sell
170,663
-92,437
-35% -$1.66M ﹤0.01% 3064
2022
Q4
$3.93M Buy
263,100
+242,674
+1,188% +$4.64M ﹤0.01% 2728
2022
Q3
$456K Sell
20,426
-44,207
-68% -$970K ﹤0.01% 4414
2022
Q2
$1.08M Sell
64,633
-51,888
-45% -$1.11M ﹤0.01% 3670
2022
Q1
$3.49M Buy
116,521
+22,283
+24% +$541K ﹤0.01% 2907
2021
Q4
$2.89M Buy
94,238
+83,354
+766% +$2.63M ﹤0.01% 3394
2021
Q3
$343K Sell
10,884
-19,727
-64% -$664K ﹤0.01% 4962
2021
Q2
$1.12M Sell
30,611
-12,650
-29% -$417K ﹤0.01% 4089
2021
Q1
$1.5M Buy
43,261
+34,849
+414% +$1.51M ﹤0.01% 3851
2020
Q4
$350K Buy
8,412
+7,873
+1,461% +$356K ﹤0.01% 4865
2020
Q3
$23K Buy
+539
New +$20.6K ﹤0.01% 6206

Other funds holding RLAY